stage II prostate cancer
Showing 9976 - 10000 of >10,000
Cervical Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)
Not yet recruiting
- Cervical Cancer
- Toripalimab
- +3 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2021
Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)
Not yet recruiting
- Metastatic Microsatellite-stable Colorectal Cancer
- (no location specified)
Sep 1, 2023
Recurrent Classic Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Nivolumab)
Recruiting
- Recurrent Classic Hodgkin Lymphoma
- Brentuximab Vedotin
- Nivolumab
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 16, 2022
Prostate Cancer Trial (PSA prostate cancer vaccine, incomplete Freund's adjuvant)
Completed
- Prostate Cancer
- PSA prostate cancer vaccine
- incomplete Freund's adjuvant
- (no location specified)
Oct 31, 2019
Prospective Research for Elderly Early Breast Cancer Patients
Recruiting
- Breast Cancer Female
- operation
- Bisphosphonate
-
Beijing, ChinaPeking Union Medical College Hospital
Dec 26, 2022
Age-Related Macular Degeneration, Geographic Atrophy Trial in United States (smaller incision, new generation implantable
Recruiting
- Age-Related Macular Degeneration
- Geographic Atrophy
- smaller incision, new generation implantable miniature telescope (SING-IMT)
-
Pasadena, California
- +7 more
Aug 5, 2022
MR Radiomic Features in Prostate Cancer
Recruiting
- Prostate Cancer
-
Milano, ItalyIRCCS Ospedale San Raffaele
Feb 9, 2021
Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Ofatumumab
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2021
Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)
Not yet recruiting
- Advanced Intrahepatic Cholangiocarcinoma
- (no location specified)
Sep 30, 2022
Sintilimab in Combination With Chemoradiotherapy in High-risk
Recruiting
- Nasopharyngeal Carcinoma
- Sintilimab
- Sintilimab (PD-1 Antibody)
-
Nanning, Guangxi, ChinaGuangxi Medical University Cancer Hospital
Jan 29, 2023
Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III Trial (MSOT)
Not yet recruiting
- Melanoma, Stage I
- +2 more
- MSOT
- (no location specified)
Jul 15, 2022
Colorectal Cancer Trial in Duarte (biological, drug, genetic, other, procedure)
Active, not recruiting
- Colorectal Cancer
- bevacizumab
- +13 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 3, 2021
Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients
Completed
- Catheter Related Complication
- Doppler Ultrasound
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata
Aug 1, 2023
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Gastric and Pancreatic Cancers in Latin America
Not yet recruiting
- Gastric Cancer
- +2 more
- Observational study
- (no location specified)
Jun 20, 2023
Gastritis, H. Pylori Infection and Atrophic Gastritis in
Completed
- Gastritis, Atrophic
- +3 more
- High-Definition white light endoscopy.
- High-definition magnification with digital chromoendoscopy.
-
Guayaquil, Guayas, EcuadorEcuadorian Institute of Digestive Diseases
Feb 9, 2021
Attention Deficit Disorder With Hyperactivity Trial (Neurological examinations)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurological examinations
- (no location specified)
May 16, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Australia (HP518 - Dose Escalation, HP518 - Dose expansion)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 - Dose expansion
-
Albury, New South Wales, Australia
- +4 more
May 5, 2022
Triple Negative Breast Tumors, Breast Cancer Trial in Chicago (Pembrolizumab, Mifepristone)
Active, not recruiting
- Triple Negative Breast Neoplasms
- Breast Cancer
-
Chicago, IllinoisUniversity of Chicago
Nov 12, 2021
Prostate Cancer Trial in Los Angeles (ezetimibe 10mg-simvastatin 40mg)
Completed
- Prostate Cancer
- ezetimibe 10mg-simvastatin 40mg
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 28, 2021
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)
Recruiting
- Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Glofitamab, Poseltinib, Lenalidomide
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 28, 2022